Seasonal Allergic Conjunctivitis

• FDA approval · 2025-04-15
  FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  FDA approved a supplemental application for PATADAY ONCE DAILY RELIEF (olopatadine hydrochloride) from Alcon Laboratories, expanding the lab…

• FDA approval · 2025-01-28
  FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (ARMAS PHARMACEUTICALS INC.)

  FDA approves a supplemental application for Loteprednol Etabonate from Armas Pharmaceuticals Inc. under ANDA 212080, finalizing the status o…

• FDA approval · 2024-12-18
  FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)

  FDA approved Somerset Therapeutics' original application for olopatadine hydrochloride ophthalmic solution as a generic treatment for allerg…

• FDA approval · 2021-02-10
  FDA Approved: LOTEPREDNOL ETABONATE — Original Application (ARMAS PHARMACEUTICALS INC.)

  FDA approved the original application for Loteprednol etabonate ophthalmic suspension from Armas Pharmaceuticals, establishing the generic c…

• FDA approval · 2020-12-18
  FDA Approved: OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Incorporated)

  FDA approves a supplemental application for olopatadine hydrochloride ophthalmic solution by Bausch & Lomb, updating the product's approval.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2020-08-06
  FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application from Apotex Corp. for olopatadine hydrochloride (generic ophthalmic antihistamine). The approval cov…

• FDA approval · 2020-01-28
  FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approves the original application for olopatadine hydrochloride, a generic antihistamine used to treat allergic conjunctivitis.

• FDA approval · 2018-06-06
  FDA Approved: PRED FORTE — Supplemental Application (Allergan, Inc.)

  The FDA approved a supplemental application for PRED FORTE (prednisolone acetate ophthalmic suspension) submitted by Allergan, Inc.

• FDA approval · 2017-06-28
  FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (GLENMARK THERAPEUTICS INC., USA)

  FDA approves Glenmark's generic olopatadine hydrochloride ophthalmic solution for allergic conjunctivitis in an Original Application.

• FDA approval · 2017-01-31
  FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved OLOPATADINE HYDROCHLORIDE ophthalmic solution under an Original Application for allergic conjunctivitis. The applicant is Padag…

• FDA approval · 2015-06-30
  FDA Approved: PATADAY TWICE A DAY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  FDA approved a supplemental application for Pataday Twice a Day Relief (olopatadine hydrochloride) by Alcon Laboratories, Inc.

• FDA approval · 2015-01-30
  FDA Approved: PATADAY ONCE DAILY RELIEF — Original Application (Alcon Laboratories, Inc.)

  FDA approved Pataday Once Daily Relief (olopatadine hydrochloride) from Alcon Laboratories in an Original Application for the treatment of a…

• FDA approval · 2013-12-16
  FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (Bausch & Lomb Americas Inc.)

  The FDA approved a supplemental application for Loteprednol Etabonate (Lotemax) from Bausch & Lomb Americas Inc.

• FDA approval · 2011-10-31
  FDA Approved: EPINASTINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)

  The FDA approved Somerset Therapeutics' epinastine hydrochloride as a generic product under an original ANDA for the treatment of allergic c…

• FDA approval · 2010-09-27
  FDA Approved: NAPHAZOLINE HCI AND PHENIRAMINE MALEATE — Original Application (Altaire Pharmaceuticals Inc.)

  FDA approved Altaire Pharmaceuticals' combination eye drops containing naphazoline hydrochloride and pheniramine maleate under an Original A…

• FDA approval · 2008-12-01
  FDA Approved: ACULAR LS — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for ACULAR LS (ketorolac tromethamine) by Allergan, Inc. This action updates the product's labeling.

• FDA approval · 2007-04-26
  FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  FDA supplemental approval granted for Pataday Once Daily Relief with olopatadine hydrochloride, expanding labeling for once-daily dosing in …